Trabectedin in Advanced High-Grade Uterine Leiomyosarcoma: A Case Report Illustrating the Value of18FDG-PET-CT in Assessing Treatment Response
We report the case of a 60-year-old woman with metastatic high-grade uterine leiomyosarcoma who achieved a delayed response to second-line therapy with the marine-derived drug trabectedin (Yondelis®, PharmaMar). We used 2-deoxy-2-[18F] fluorodeoxyglucose (FDG)-positron emission tomography (PET-CT) i...
Huvudupphovsmän: | , , , |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
Karger Publishers
2014-02-01
|
Serie: | Case Reports in Oncology |
Ämnen: | |
Länkar: | http://www.karger.com/Article/FullText/355224 |